Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

Nanoparticles larger than the reported mesh-pore size range (10–200 nm) in mucus have been thought to be much too large to undergo rapid diffusional transport through mucus barriers. However, large nanoparticles are preferred for higher drug encapsulation efficiency and the ability to provide sustained delivery of a wider array of drugs. We used high-speed multiple-particle tracking to quantify transport rates of individual polymeric particles of various sizes and surface chemistries in samples of fresh human cervicovaginal mucus. Both the mucin concentration and viscoelastic properties of these cervicovaginal samples are similar to those in many other human mucus secretions. Unexpectedly, we found that large nanoparticles, 500 and 200 nm in diameter, if coated with polyethylene glycol, diffused through mucus with an effective diffusion coefficient (Deff) only 4- and 6-fold lower than that for the same particles in water (at time scale τ = 1 s). In contrast, for smaller but otherwise identical 100-nm coated particles, Deff was 200-fold lower in mucus than in water. For uncoated particles 100–500 nm in diameter, Deff was 2,400- to 40,000-fold lower in mucus than in water. Much larger fractions of the 100-nm particles were immobilized or otherwise hindered by mucus than the large 200- to 500-nm particles. Thus, in contrast to the prevailing belief, these results demonstrate that large nanoparticles, if properly coated, can rapidly penetrate physiological human mucus, and they offer the prospect that large nanoparticles can be used for mucosal drug delivery.

[1]  T. Park,et al.  Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release , 1999, Pharmaceutical Research.

[2]  I. Gipson,et al.  MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. , 1999, Biology of reproduction.

[3]  D. Wirtz,et al.  Efficient active transport of gene nanocarriers to the cell nucleus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Sheehan,et al.  Structure and macromolecular properties of cervical mucus glycoproteins. , 1989, Symposia of the Society for Experimental Biology.

[5]  K. Whaley,et al.  Residence half-life of IgG administered topically to the mouse vagina. , 1996, Biology of reproduction.

[6]  T. Thigpen The role of chemotherapy in the management of carcinoma of the cervix. , 2003, Cancer journal.

[7]  D. Thornton,et al.  From mucins to mucus: toward a more coherent understanding of this essential barrier. , 2004, Proceedings of the American Thoracic Society.

[8]  N. Jones,et al.  The rheology of nasal mucus: a review. , 1998, Clinical otolaryngology and allied sciences.

[9]  Denis Wirtz,et al.  Particle Tracking Microrheology of Complex Fluids , 1997 .

[10]  V. Kuonen,et al.  The tear film and ocular mucins , 2004, Veterinary ophthalmology.

[11]  A. Allen,et al.  Gastroduodenal mucosal protection. , 1993, Physiological reviews.

[12]  Y. Huang,et al.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[13]  M. Alonso,et al.  Transmucosal macromolecular drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[14]  J. Hanes,et al.  Synthesis and characterization of PEG-based ether-anhydride terpolymers: Novel polymers for controlled drug delivery , 2004 .

[15]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[16]  K. Janes,et al.  Polysaccharide colloidal particles as delivery systems for macromolecules. , 2001, Advanced drug delivery reviews.

[17]  A. Hickey,et al.  Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy. , 2002, Advanced drug delivery reviews.

[18]  M D Donovan,et al.  Drug transfer through mucus. , 2001, Advanced drug delivery reviews.

[19]  M. Maiman,et al.  Isotretinoin for Low‐Grade Cervical Dysplasia in Human Immunodeficiency Virus‐Infected Women , 2002, Obstetrics and gynecology.

[20]  J. Vergnes,et al.  Fractionation and partial characterization of macromolecular components from human ocular mucus. , 1983, Experimental eye research.

[21]  D. Wirtz,et al.  Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus , 2004, Biotechnology progress.

[22]  U. Ulmsten,et al.  Isolation and characterization of human cervical-mucus glycoproteins. , 1983, The Biochemical journal.

[23]  P. Hees,et al.  A Self-Sampling Method to Obtain Large Volumes of Undiluted Cervicovaginal Secretions , 2003, Sexually transmitted diseases.

[24]  S. Smedt,et al.  Cystic fibrosis sputum: a barrier to the transport of nanospheres. , 2000, American journal of respiratory and critical care medicine.

[25]  Elazer R. Edelman,et al.  Adv. Drug Delivery Rev. , 1997 .

[26]  K. Whaley,et al.  Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. , 1999, Emerging infectious diseases.

[27]  R. Roden,et al.  Vaccination to prevent and treat cervical cancer. , 2004, Human pathology.

[28]  A. Herp,et al.  Studies on the isolation and composition of human ocular mucin. , 1988, Experimental eye research.

[29]  S. Hillier,et al.  Comparison of Clindamycin Phosphate Vaginal Cream With Triple Sulfonamide Vaginal Cream in the Treatment of Bacterial Vaginosis , 2001, Sexually transmitted diseases.

[30]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[31]  Patrick J. Sinko,et al.  Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin , 1997 .

[32]  Axel Fischer,et al.  Distribution of Respiratory Mucin Proteins in Human Nasal Mucosa , 2003, The Laryngoscope.

[33]  J. Jassem,et al.  Chemotherapy in the primary treatment of cervical carcinoma. , 2005, Critical reviews in oncology/hematology.

[34]  I. Gipson Mucins of the human endocervix. , 2001, Frontiers in bioscience : a journal and virtual library.

[35]  A. I. Yudin,et al.  Human cervical mucus and its interaction with sperm: a fine-structural view. , 1989, Biology of reproduction.

[36]  K. Whaley,et al.  Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes , 1996, Nature Biotechnology.

[37]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[38]  S. S. Olmsted,et al.  Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models , 2001, Sexually transmitted diseases.

[39]  W. Saltzman,et al.  Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[40]  K. Whaley,et al.  Controlled vaginal delivery of antibodies in the mouse. , 1992, Biology of reproduction.

[41]  Delie,et al.  Evaluation of nano- and microparticle uptake by the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[42]  A. Dueñas-González,et al.  Modern management of locally advanced cervical carcinoma. , 2003, Cancer treatment reviews.

[43]  D. Wirtz,et al.  Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport* , 2003, Journal of Biological Chemistry.

[44]  F. Ahsan,et al.  The vagina as a route for systemic drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Anthony J. Hickey,et al.  Pharmaceutical Inhalation Aerosol Technology , 2003 .

[46]  David C. Martin,et al.  Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. , 2006, Biomaterials.

[47]  L. Szentkuti,et al.  Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon , 1997 .

[48]  Junghae Suh,et al.  Real-time multiple-particle tracking: applications to drug and gene delivery. , 2005, Advanced drug delivery reviews.

[49]  T. J. Nickola,et al.  Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. , 2001, American journal of respiratory cell and molecular biology.